Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.245

Significance of Expression of Human METCAM/MUC18 in Nasopharyngeal Carcinomas and Metastatic Lesions  

Lin, Jin-Ching (Department of Radiation Oncology, Taichung Veterans General Hospital)
Chiang, Cheng-Feng (Department of Microbiology and Immunology, Emory University School of Medicine)
Wang, Shur-Wern (Department of Microbiology and Immunology, Emory University School of Medicine)
Wang, Wen-Yi (Department of Basic Medicine, Hung Kuang University)
Kwan, Po-Cheung (Department of Pathology, Taichung Veterans General Hospital)
Wu, Guang-Jer (Department of Microbiology and Immunology, Emory University School of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 245-252 More about this Journal
Abstract
Human METCAM/MUC18, a cell adhesion molecule (CAM) in the immunoglobulin-like gene super family, plays a dual role in the progression of several epithelium cancers; however, its role in the nasopharyngeal carcinoma (NPC) remains unclear. To initiate the study we determined human METCAM/MUC18 expression in tissue samples of normal nasopharynx (NP), NPCs, and metastatic lesions, and in two established NPC cell lines. Immunoblotting analysis was used for the determination in lysates of frozen tissues, and immunohistochemistry (IHC) for expression in formalin-fixed, paraffin-embedded tissue sections of 7 normal nasopharynx specimens, 94 NPC tissue specimens, and 3 metastatic lesions. Human METCAM/MUC18 was expressed in 100% of the normal NP, not expressed in 73% of NPC specimens (or expressed at very low levels in only about 27% of NPC specimens), and expressed again in all of the metastatic lesions. The level of human METCAM/MUC18 expression in NPC tissues was about one fifth of that in the normal NP and metastatic lesions. The low level of human METCAM/MUC18 expression in NPC specimens was confirmed by a weak signal of RT-PCR amplification of the mRNA. Low expression levels of human METCAM/MUC18 in NPC tissues were also reflected in the seven established NPC cell lines. These findings provided the first evidence that diminished expression of human METCAM/MUC18 is an indicator for the emergence of NPC, but increased expression then occurs with metastatic progression, suggesting that huMETCAM/MUC18, perhaps similar to TGF-${\beta}$, may be a tumor suppressor, but a metastasis promoter for NPC.
Keywords
HuMETCAM/MUC18; immunoblot; immunohistochemistry; RT-PCR; NPC progression;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zeng GF, Cai SX, Wu GJ (2011). Up-regulation of METCAM/ MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells. BMC Cancer, 11, 113.   DOI   ScienceOn
2 Yoshizaki T (2002). Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol, 17, 845-50.
3 Yu Y, Dong W, Zhou X, et al (2004). The significance of soluble intercellular adhesion molecule 1 (ICAM-1) and transformation growth factor alpha in patients with nasopharyngeal carcinomas. Acta Otolaryngol Head Neck Surg, 130, 1205-8.   DOI   ScienceOn
4 Zeng GF, Cai SX, Liu Y, et al (2012a). METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells. Gene, 492, 229-38.   DOI   ScienceOn
5 Zeng Q, Li W, Lu D, et al (2012b). CD146, an epithelialmesenchymal transition inducer, is associated with triplenegative breast cancer. Proc Natl Acad Sci USA, 109, 1127-32.   DOI
6 Wu GJ, Fu P, Chiang C, et al (2005). Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urology, 173, 1778-83.   DOI   ScienceOn
7 Wu GJ (2004). The role of MUC18 in prostate carcinoma. In: Hayat MA, editor. Immunohistochemistry and in situ hybridization of human carcinoma. Vol 2. Molecular pathology, lung carcinoma, breast carcinoma, and prostate carcinoma. Amsterdam: Elsevier Science/Academic Press; pp. 347-58.
8 Wu GJ, Peng Q, Fu P, et al (2004). Ectopic expression of human MUC18 increases metastasis of human prostate cancer cells. Gene, 327, 201-13.   DOI   ScienceOn
9 Wu GJ (2005). METCAM/MUC18 expression and cancer metastasis. Curr Genomics, 6, 333-49.   DOI   ScienceOn
10 Wu GJ, Fu P, Wang SW, et al (2008). Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res, 6, 1666-77.   DOI   ScienceOn
11 Wu GJ, Wu MWH, Liu Y (2011). Enforced expression of human METCAM/MUC18 increases the tumorigenesis of human prostate cancer cells in nude mice. J Urology, 185, 1504-12.   DOI   ScienceOn
12 Wu GJ (2012). Dual roles of METCAM in the in the progression of different cancers. J Oncol, 2012, 853797.
13 Schlagbauer-Wadl H, Jansen B, Muller M, et al (1999). Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int J Cancer, 81, 951-5.   DOI
14 Xie S, Luca M, Huang S, et al (1997). Expression of MCAM/ MCU18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res, 57, 2295-303.
15 Yang H., Wang SW, Liu Z, et al (2011). Isolation and characterization of murine MUC18 cDNA gene, and correlation of MUC18 expression in murine melanoma cell lines with metastatic ability. Gene, 265, 133-45.
16 Yi ZC, Wang H, Zhang GY, et al (2006). Downregulation of connexin 43 in nasopharyngeal carcinoma cells is related to promoter methylation. Oral Oncol, 43, 898-904.
17 McGary EC, Heimberger A, Mills L, et al (2003). A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vitro. Clin Cancer Res, 9, 6560-6.
18 Raab-Traub N (1992). Epstein-Barr virus and nasopharyngeal carcinoma. Semin in Cancer Biol, 3, 297-307.
19 Roberts AB, Wakefield LM (2003). The two faces of transforming growth factor beta (TGF-${\beta}$) in carcinogenesis. Proc Natl Acad Sci USA, 100, 8621-3.   DOI   ScienceOn
20 Shih IM (1999). The role of CD146 (Mel-CAM) in biology and pathology. J Pathol, 189, 4-11.   DOI
21 Tsai CN, Tsai CL, Tse KP, et al (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the down-regulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA, 99, 10084-9.   DOI   ScienceOn
22 Wei W, Sham JS (2005). Nasopharyngeal carcinoma. Lancet, 365, 2041-54.   DOI   ScienceOn
23 Li Z, Ren Y, Lin SX, et al (2004). Association of E-cadherin and ${\beta}$-catenin with metastasis in nasopharyngeal carcinomas. Chin Med J, 117, 1232-9.
24 Wei YS, Zhu YH, Du B, et al (2007). Association of transforming growth factor ${\beta}$1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta, 380, 165-9.   DOI   ScienceOn
25 Wu GJ, Varma VA, Wu MWH, et al (2001a). Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate, 48, 305-15.   DOI   ScienceOn
26 Wu GJ, Wu MWH, Wang SW, et al (2001b). Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cells and tissues with malignant progression. Gene, 279, 17-31.   DOI   ScienceOn
27 Lee AWM, Ng WT, Chan YH, et al (2012). The battle against nasopharyngeal cancer. Radiother Oncol, 104, 272-278.   DOI   ScienceOn
28 Lehmann JM, Reithmuller G, Johnson JP (1989). MUC18, a marker of tumor progression in human melanoma. Proc Natl Acad Sci USA, 86, 9891-5.   DOI
29 Li Q, Yu Y, Bischoff J, et al (2003). Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathology, 201, 296-302.   DOI   ScienceOn
30 Ausubel FM, Brent R, Kingston RE, et al (1987). Current Protocols in Molecular Biology. New York: Green Publishing Associates and Wiley-Interscience Press; 4.9.
31 Cavallaro U, Christofori G (2004). Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer, 4, 118-32.   DOI   ScienceOn
32 Lung HL, Bangarusamy DK, Xie D, et al (2005). THY1 is a candidate tumor suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene, 24, 6525-32.
33 Lin CT, Wong CI, Chan WY, et al (1990). Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest, 62, 713-24.
34 Lin CT, Chan WY, Chen W, et al (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest, 68, 716-27.
35 Lung HL, Cheng Y, Kumaran MK, et al (2004). Fine mapping of the 11Q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer, 112, 628-35.   DOI   ScienceOn
36 Chiang CF, Son EL, Wu GJ (2005). Oral treatment of male TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Prostate, 64, 408-18.   DOI   ScienceOn
37 Chomczyuski P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem, 162, 156-9.
38 Craefor NPS, Hunter KW (2006) New perspectives on hereditary influences in metastatic progression. Trends in Genetics, 22, 555-61.   DOI   ScienceOn
39 De The' G (1982). Epidemiology of Epstein-Barr virus and associated diseases. In: Roizman B, editor. The Herpesviruses. New York: Plenum Press; Vol 1, pp. 25-87.
40 Hassen E, Farhat K, Gabbouj S, et al (2007). TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet, 175, 41-6.   DOI   ScienceOn
41 Ho JHC (1972). Current knowledge of the epidemiology of nasopharyngeal carcinoma (NPC). In: Biggs P, de The' G, Payne L, eds. Oncogenesis and Herpesviruses. Lyon: IARC; pp. 357-66.
42 Krishna SM, Kattoor J, Balaram P (2005). Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomarker, 1, 271-7.
43 Huang GW, Mo WN, Kuang GQ, et al (2001). Expression of p16, nm-23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinomas. Laryngoscope, 111, 1465-71.   DOI   ScienceOn